Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AACR 2026
Research
AACR: NCI leader assures researchers that ‘funding is strong’
NCI Director Letai envisions a return to normalcy for cancer research funding after last year's turmoil.
Darren Incorvaia
Apr 22, 2026 10:00am
AACR: Revolution rolls on in pancreatic cancer as RAS wave rises
Apr 21, 2026 5:35pm
With global goals, Zai Lab offers China reality check
Apr 20, 2026 2:12pm
AACR: Genentech veteran engineers ‘smart’ cancer drug startup
Apr 19, 2026 6:05pm
AACR: Pazdur bemoans state of FDA, warns of political influence
Apr 18, 2026 4:00am
AACR: Merck unveils PD-1xVEGF bispecific data in NSCLC
Apr 17, 2026 3:00pm
